Development Payments. 6.2.3. 3112 Product Inovio shall be responsible for operational execution of the 3112 Development Plan in cooperation with MedImmune via the JCSC through the Transition Period. The 3112 Development Plan shall mean the plan for conduct of ongoing and planned 3112 Trials (XXX-000, XXX-000 and HPV-007) and include the budget which is current and agreed as of the Effective Date. [XXXXXXX]. After the Transition Period, MedImmune shall be solely responsible for the Development, Manufacturing and Commercialization, including operational execution and financial responsibility thereof, of the 3112 Product in the 3112 Field in the Territory.
Appears in 3 contracts
Samples: License Agreement, Dna Cancer Vaccine Collaboration and License Agreement, License Agreement (Inovio Pharmaceuticals, Inc.)
Development Payments. 6.2.3. 3112 Product Inovio shall be responsible for operational execution of the 3112 Development Plan in cooperation with MedImmune via the JCSC through the Transition Period. The 3112 Development Plan shall mean the plan for conduct of ongoing and planned 3112 Trials (XXX-000HPV-004, XXX-000 HPV-005 and HPV-007) and include the budget which is current and agreed as of the Effective Date. [XXXXXXX]. After the Transition Period, MedImmune shall be solely responsible for the Development, Manufacturing and Commercialization, including operational execution and financial responsibility thereof, of the 3112 Product in the 3112 Field in the Territory.
Appears in 1 contract
Samples: License Agreement
